Robert Kornegay
Adjunct Professor Rob Kornegay is a partner at Wilson Sonsini Goodrich & Rosati.
Professor Kornegay represents technology and growth companies at all stages of their development, from seed-stage start-ups to early-stage public companies to more mature public companies. He structures, manages, and negotiates merger and acquisition transactions, public equity offerings, private placement equity and debt transactions, strategic alliances, spin-outs, recapitalizations, and other corporate reorganizations.
Professor Kornegay regularly advises public and private companies and their management on a broad range of corporate matters, including corporate governance responsibilities, equity incentive plans and arrangements, employment matters, intellectual property issues, regulatory compliance, and commercial transactions. In addition, he often counsels entrepreneurs on the formation of their companies, equity structures, and negotiations with seed and venture capital investors, and also represents and advises venture capital firms and other institutions investing in technology companies.
Professor Kornegay regularly represents clients in the life sciences and information technology industries. Representative clients include Fluidigm Corporation, Occam Networks, RealNetworks, Copart, Maxlinear, Oncothyreon, and Transcept Pharmaceuticals.
Professor Kornegay also serves as adjunct professor at the Santa Clara University School of Law. He received an A.B. in economics from Georgetown University, an M.B.A. with a specialization in finance from The University of Chicago Graduate School of Business, and a J.D. from the University of California, Los Angeles, where he was comment editor of the UCLA Law Review.